Muscle-derived stem cells in tissue engineering: Defining cell properties suitable for construct design

Histology and Histopathology

Volumn 20, Issue 3, 2005, Pages 891-899

  Buján, Julia ^a   Pascual, G ^a   Corrales, C ^a   Gomez Gill V ^a   Rodriguez M ^a   Bellon J M ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Cell differentiation; Muscle derived stem cells; Regenerative therapy; Tissue engineering

Indexed keywords

CADHERIN; CD34 ANTIGEN; MYOGENIC FACTOR 5; VIMENTIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL DIFFERENTIATION; CELL ISOLATION; CELL LINEAGE; CELL MIGRATION; CELL POPULATION; CELL PROLIFERATION; CELL STRUCTURE; CELL TYPE; CONTROLLED STUDY; IMMUNOFLUORESCENCE; IN VITRO STUDY; MUSCLE DEVELOPMENT; MYOFIBROBLAST; NONHUMAN; PROTEIN EXPRESSION; SCANNING ELECTRON MICROSCOPY; STEM CELL; TISSUE ENGINEERING; WESTERN BLOTTING;

ACTINS; ANIMALS; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELLS, CULTURED; DESMIN; FIBROBLASTS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; MUSCLES; MYOSINS; RABBITS; STEM CELLS; TIME FACTORS; TISSUE ENGINEERING; VIMENTIN;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 21644477982     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Asakura A., Komaki M. and Rudnicki M.A. (2001). Muscle satellite cells are multipotential stem cells that exhibit myogenic, osteogenic and adipogenic differentiation. Differentiation 68, 245-253.
2. Asakura A., Seale P., Girgis-Gabardo A. and Rudnicki M.A. (2002). Myogenic specification of side population cells in skeletal muscle. J. Cell Biol. 159, 123-134.
3. Beauchamp J.R., Heslop, L., Yu, D.S.W., Tajbakhshs S., Kelly R.G., Wernig A., Buckingham M.E., Partridge T.A and Zammit P.S. (2000). Expression of CD34 and Myf5 defines the majority of quiescent adult skeletal muscle satellite cells. J. Cell Biol. 151, 1221-1233.
4. Bellón J.M., Buján J., Garcia-Honduvilla N., Hernando A. and Navlet J. (1993). Endothelial cells seeding on PTFE vascular prostheses coated with a fibroblastic matriz. Ann. Vasc. Surg. 7, 549-555.
5. Chen J.C.J. and Goldhamer D.J. (2003). Skeletal muscle stem cells. Rep. Biol. Endocrinol. I, 101.
6. Fuchs E. and Segre J.A. (2000). Stem cells: A new lease on life. Cell 100, 143-155.
7. Hernando A., Garcia-Honduvilla N., Bellón J.M., Buján J. and Navlet J. (1994). Coatings for vascular prostheses: Mesothelial cells express specific markers for muscle and have biological activity similar to that of endothelial cells. Eur. J. Vasc. Surg. 8, 531-536.
8. Hinz B. and Gabbiani G. (2003). Mechanisms of force generation and transmission by myofibroblasts. Curr. Opin. Biotechnol. 14, 538-546.
9. Jackson K.A., Mi T. and Goodell M.A. (1999). Hematopoietic potential of stem cells isolated from murine skeletal muscle. Proc. Natl. Acad. Sci. USA 96, 14482-14486.
10. Janes S.M., Lowell S. and Hutter C. (2002). Epidermal stem cells. J. Pathol. 197, 479-491.
11. Kablar B., Krastel K., Tajbakhsh S. and Rudnicky M.A. (2003). Myf 5 and MyoD activation define independent myogenic compartments during embryonic development. Dev. Biol. 258, 307-318
12. Kocher O, Skalli O, Cerutti D., Gabbiani F. and Gabbiani G. (1985). Cytoskeletal features of rat aortic cells during development. An electron microscopic, immunohistochemical, and biochemical study. Circ. Res. 56, 829-838.
13. Kuehnle I. and Goodell M.A. (2002). The therapeutic potential of stem cells from adults. Br. Med. J. 325, 372-376.
14. Mirabet V., Lequerica J.L., Montero J.A., Hurtado C. and Carbonell F. (2000). Cultivo in vitro de células satélite de músculo esquético. ¿Una alternativa terapeútica para el tratamiento de la cardiopatía isquémica?. Investigación Cardiovascular 3, 91-103.
15. Morgan J.E. and Partridge T.A. (2003). Muscle satellite cells. Int. J. Biochem. Cell Biol. 35, 1151-1156.
16. Rao M.S. and Mattson M.P. (2001). Stem cells and aging: expanding the possibilities. Mechanism. Aging Dev. 122, 713-734.
17. Seale P. and Rudnicki M.A. (2000). A new look at the origin, function and stem-cell status of muscle satellite cells. Dev. Biol. 218, 115-124.
18. Seale P., Sabourin L., Girgis-Gabardo A., Mansouri A., Gruss P. and Rudnicki M.A. (2000). Pax7 is required for the specification of myogenic satellite cells. Cell 102, 777-786.
19. Stewart J.D., Masi T.L., Cumming AE., Molnar G.M., Wentworth B.M, Sampath K., McPherson J.M. and Yaeger P.C. (2003). Characterization of proliferating human skeletal muscle-derived cells in vitro: differential modulation of myoblast markers by TGF-β2. J. Cell Physiol. 196, 70-78.
20. Stock U.A. and Vacanti J.P. (2001). Tissue enginnering: current state and prospects. Annu. Rev. Med. 52, 443-451.
21. Tajbakhsh S. (2003). Stem cells to tissue: molecular, cellular and anatomical heterogeneity in skeletal muscle. Curr. Opin. Genet. Dev. 13, 413-422.
22. Vacanti J.P. and Langer R. (1999). Tissue enginnering: the design and fabrication of living replacement devices for surgical reconstruction and transplantation. Lancet 354, 32-34.
23. Vants A., Tolley N.S., Polak J.M. and Buttery L.D. (2002). Stem cells sources and applications. Clin. Otolaryngol. 27, 227-232.
24. Zammit P. and Beauchamp J. (2001). The skeletal muscle satellite cell: stem cell or son of stem cell? Differentiation 68, 193-204.